Bone and Soft Tissue Tumors, Clinical Features
Conditions
Brief summary
It is planned to prospectively collect, collate and report real-world clinical data of BSTS patients treated in our hospital in the next ten years to evaluate the changes in clinical characteristics, treatment patterns and survival information of these patients, in order to provide reference for clinical treatment and research of this type of tumor.
Detailed description
It is planned to prospectively collect, collate and report real-world clinical data of BSTS patients treated in our hospital in the next ten years to evaluate the changes in clinical characteristics, treatment patterns and survival information of these patients, in order to provide reference for clinical treatment and research of this type of tumor. This study is a single-center, prospective, real-world observational study that plans to enroll all eligible patients. Basic information, treatment methods, and prognostic information of these patients were collected.
Interventions
OTHERNO Intervention
NO Intervention
Sponsors
Henan Cancer Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
6 Years to 99 Years
Healthy volunteers
No
Inclusion criteria
All ages, male and female. The pathological diagnosis of BSTS in our hospital was a subtype. Has received at least one hospitalization in this hospital. The target lesions could be evaluated according to the efficacy evaluation criteria of solid tumor (RECIST; Version 1.1) Measure diameter changes.
Exclusion criteria
No definite pathology.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 6/5000 Progression-free survival | Up to approximately 48months | The time from the first use of the treatment to the observation of disease progression |
| Overall survival | Up to approximately 120months | Pathologically confirmed events leading to death |
Countries
China
Contacts
Primary ContactWang Jiaqiang, Dr.
Outcome results
None listed